Stock INKT MINK THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. MiNK Therapeutics, Inc.

Equities

INKT

US6036931029

Market Closed - Nasdaq
Other stock markets
 02:00:01 03/05/2024 am IST 		5-day change 1st Jan Change
0.9694 USD +1.77% Intraday chart for MiNK Therapeutics, Inc. +9.04% -9.40%
21/03 Transcript : MiNK Therapeutics, Inc., Q4 2023 Earnings Call, Mar 21, 2024
21/03 MiNK Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts MiNK Therapeutics Price Target to $10 From $7, Maintains Buy Rating
MT
Evercore ISI Adjusts MiNK Therapeutics' Price Target to $3 From $4, Keeps Outperform Rating
MT
HC Wainwright Initiates MiNK Therapeutics at Buy, Sets Price Target at $7
MT
B. Riley Lowers MiNK Therapeutics' Price Target to $7 from $10, Keeps Buy Rating
MT
B. Riley Lowers MiNK Therapeutics' Price Target to $10 from $24 After Revising Cost Capital Assumptions, Keeps Buy Rating
MT
B. Riley Starts MiNK Therapeutics at Buy with $24 PT, Notes 'Attractive' Valuation, Disruptive Potential of iNKT Platform
MT
William Blair Initiates Coverage on MiNK Therapeutics With Outperform Rating
MT
Evercore ISI Starts MiNK Therapeutics at Outperform With $30 Price Target
MT
Baird Starts MiNK Therapeutics at Outperform With $26 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INKT Stock
  4. News MiNK Therapeutics, Inc.
  5. Analyst Reco.